Concepedia

Author

Martin Schwaiblmair

Ludwig-Maximilians-Universität MünchenORCID

Also Known As

M Schwaiblmair, M. Schwaiblmair, MARTIN SCHWAIBLMAIR, Martin G Schwaiblmair, Martin Schwaiblmair, Peter Schramm, Toni Anusic

130

Publications

4.2K

Citations

33

H-Index

89

Concepts

All Affiliations

Ludwig-Maximilians-Universität MünchenUniversity Hospital AugsburgLMU KlinikumHeidelberg UniversityUniversitätsmedizin Greifswald
MS

About

Martin Schwaiblmair is an author at Ludwig-Maximilians-Universität München specializing in medicine, cardiovascular disease, and public health.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

24

1.9K

2

Public Health

11

11

758

3

Health Sciences

2

2

56

4

Education

1

1

36

5

Engineering

1

1

104

Martin Schwaiblmair

×

46

Publications

3.7K

Citations

30

H-Index

YearCitations

Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure

Jörg Koglin, Sinan Pehlivanli, Martin Schwaiblmair,

Journal of the American College of Cardiology

2001

406

Drug Induced Interstitial Lung Disease

Martin Schwaiblmair

The Open Respiratory Medicine Journal

2012

356

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension

Hanno Leuchte, Michael Holzapfel, Rainer Baumgartner,

Journal of the American College of Cardiology

2004

288

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry

Jürgen Behr, Michael Kreuter, Marius M. Hoeper,

European Respiratory Journal

2015

230

Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry

Michael Kreuter, Jeff Swigris, David Pittrow,

Respiratory Research

2017

197

Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry

Jürgen Behr, Antje Prasse, Hubert Wirtz,

European Respiratory Journal

2020

165

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial

Stefano Barco, Irene Schmidtmann, Walter Ageno,

European Heart Journal

2019

151

ELEVATED LEVELS OF INTERLEUKIN-8 AND TRANSFORMING GROWTH FACTOR-BETA IN BRONCHOALVEOLAR LAVAGE FLUID FROM PATIENTS WITH BRONCHIOLITIS OBLITERANS SYNDROME:

Andreas Elssner, F. Jaumann, Sandra Dobmann,

Transplantation

2000

144

Hemodynamic Response to Sildenafil, Nitric Oxide, and Iloprost in Primary Pulmonary Hypertension

Hanno Leuchte, Martin Schwaiblmair, Rainer Baumgartner,

CHEST Journal

2004

131

The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry

Michael Kreuter, Jeff Swigris, David Pittrow,

Respiratory Research

2019

115

Page 1